-
The U.S. Food and Drug Administration has approved the first antiepileptic drug for monotherapy in children since 1978.
-
Study: Pharmacists intervention can help keep men healthy; Interstitial cystitis study finds limited benefit in two oral drugs; FDA to inform women about menopausal hormone therapy; Wyeth issues warning about venlafaxine use in children
-
Federal incentive for pharmaceutical companies to study drugs in children has led to improved labeling for several medications. More needs to be done, though, and pharmacists can play a key role in encouraging the process, says one pediatrician.
-
The overuse of antibiotics in children may be subsiding, according to a study published in the September issue of Pediatrics.
-
Two recent warnings have led to concerns about the risks of prescribing antidepressants to children.
-
These drugs recently received final approval from the U.S. Food and Drug Administration (FDA):
-
Gemifloxacin is effective as standard treatment for the treatment of ABECB and CAP; however, in limited trials it does not seem to be more efficacious or safe than other standard drug therapy for these indications.
-
Extended hormonal contraception is drawing dramatic attention due to the desire of many women to reduce or eliminate the number of withdrawal bleeds associated with current birth control methods.
-
The final version of the recently proposed changes to the Emergency Medical Treatment and Labor Act (EMTALA) takes effect Nov. 10.
-
